MUL1 and thyroid gland carcinoma: Although more detailed experiments are necessary to elucidate the underlying expression profiling between FOXO3 and MUL1 in tissues of thyroid cancer patients, we could speculate that while p-AKT is increased, FOXO3 and MUL1 is decreased.